adding memantine to treatment of schozopherenia
Phase 3
- Conditions
- schizopherenia.Schizophrenia
- Registration Number
- IRCT20180301038906N1
- Lead Sponsor
- Mashhad University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 60
Inclusion Criteria
Schizophrenia in the relative recovery period
Use of atypical antipsychotics including risperidone and olanzapine
No other drugs (except anticholinergic and benzodiazepine)
Lack of pregnancy or breastfeeding
No serious organic disease and no drug use at the time of entering the study
Exclusion Criteria
There is serious organic disease
Pregnancy or breastfeeding
Existence of dementia
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method The condition of psychotic symptoms. Timepoint: Week 2,4,6. Method of measurement: wechsler.
- Secondary Outcome Measures
Name Time Method Cognitive and negative symptoms. Timepoint: week 2,4,6. Method of measurement: wechsler.